Robert Feil

Prof. Robert Feil

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1997 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
RFRobert Feil
Robert Feil
JWJürgen Wagner
Jürgen Wagner
DMDaniel Metzger
Daniel Metzger
PCPierre Chambon
Pierre Chambon

1 October 1996 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RFRobert Feil
Robert Feil
JBJ Brocard
J Brocard
BMB Mascrez
B Mascrez
MLM LeMeur
M LeMeur
DMD Metzger
D Metzger
PCP Chambon
P Chambon
Current mouse gene targeting technology is unable to introduce somatic mutations at a chosen time and/or in a given tissue. We report here that conditional site-specific recombination can be achieved in mice using a new version of the Cre/lox system. The Cre recombinase has been fused to a mutated ligand-binding domain of the human estrogen receptor (ER) resulting in a tamoxifen-dependent Cre recombinase, Cre-ERT, which is activated by tamoxifen, but not by estradiol. Transgenic mice were generated expressing Cre-ERT under the control of a cytomegalovirus promoter. We show that excision of a chromosomally integrated gene flanked by loxP sites can be induced by administration of tamoxifen to these transgenic mice, whereas no excision could be detected in untreated animals. This conditional site-specific recombination system should allow the analysis of knockout phenotypes that cannot be addressed by conventional gene targeting.

12 September 2014 in Circulation Research
Verified
Journal Article
Closed access
SFSusanne Feil
Susanne Feil
BFBirgit Fehrenbacher
Birgit Fehrenbacher
RLRobert Lukowski
Robert Lukowski
Frank EssmannFrank Essmann
Frank Essmann
KSKlaus Schulze-Osthoff
Klaus Schulze-Osthoff
RFRobert Feil
Robert Feil
Rationale:: Atherosclerosis is a widespread and devastating disease, but the origins of cells within atherosclerotic plaques are not well defined. Objective:: To investigate the specific contribution of vascular smooth muscle cells (SMCs) to atherosclerotic plaque formation by genetic inducible fate mapping in mice. Methods and Results:: Vascular SMCs were genetically pulse-labeled using the tamoxifen-dependent Cre recombinase, CreER T2 , expressed from the endogenous SM22α locus combined with Cre-activatable reporter genes that were integrated into the ROSA26 locus. Mature SMCs in the arterial media were labeled by tamoxifen treatment of young apolipoprotein E–deficient mice before the development of atherosclerosis and then their fate was monitored in older atherosclerotic animals. We found that medial SMCs can undergo clonal expansion and convert to macrophage-like cells that have lost classic SMC marker expression and make up a major component of advanced atherosclerotic lesions. Conclusions:: This study provides strong in vivo evidence for smooth muscle-to-macrophage transdifferentiation and supports an important role of SMC plasticity in atherogenesis. Targeting this type of SMC phenotypic conversion might be a novel strategy for the treatment of atherosclerosis, as well as other diseases with a smooth muscle component.

15 January 2003 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ALAndreas Ludwig
Andreas Ludwig
TBThomas Budde
Thomas Budde
JSJuliane Stieber
Juliane Stieber
SMSven Moosmang
Sven Moosmang
CWChristian Wahl
Christian Wahl
FHFranz Hofmann
Franz Hofmann
Hyperpolarization‐activated cation (HCN) channels are believed to be involved in the generation of cardiac pacemaker depolarizations as well as in the control of neuronal excitability and plasticity. The contributions of the four individual HCN channel isoforms (HCN1—4) to these diverse functions are not known. Here we show that HCN2‐deficient mice exhibit spontaneous absence seizures. The thalamocortical relay neurons of these mice displayed a near complete loss of the HCN current, resulting in a pronounced hyperpolarizing shift of the resting membrane potential, an altered response to depolarizing inputs and an increased susceptibility for oscillations. HCN2‐null mice also displayed cardiac sinus dysrhythmia, a reduction of the sinoatrial HCN current and a shift of the maximum diastolic potential to hyperpolarized values. Mice with cardiomyocyte‐ specific deletion of HCN2 displayed the same dysrhythmia as mice lacking HCN2 globally, indicating that the dysrhythmia is indeed caused by sinoatrial dysfunction. Our results define the physiological role of the HCN2 subunit as a major determinant of membrane resting potential that is required for regular cardiac and neuronal rhythmicity.

9 December 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JSJuliane Stieber
Juliane Stieber
SHStefan Herrmann
Stefan Herrmann
SFSusanne Feil
Susanne Feil
JLJana Löster
Jana Löster
RFRobert Feil
Robert Feil
ALAndreas Ludwig
Andreas Ludwig
Hyperpolarization-activated, cyclic nucleotide-gated cation currents, termed I f or I h , are generated by four members of the hyperpolarization-activated, cyclic nucleotide-gated cation (HCN) channel family. These currents have been proposed to contribute to several functions including pacemaker activity in heart and brain, control of resting potential, and neuronal plasticity. Transcripts of the HCN4 isoform have been found in cardiomyocytes and neurons, but the physiological role of this channel is unknown. Here we show that HCN4 is essential for the proper function of the developing cardiac conduction system. In wild-type embryos, HCN4 is highly expressed in the cardiac region where the early sinoatrial node develops. Mice lacking HCN4 channels globally, as well as mice with a selective deletion of HCN4 in cardiomyocytes, died between embryonic days 9.5 and 11.5. On average, I f in cardiomyocytes from mutant embryos is reduced by 85%. Hearts from HCN4-deficient embryos contracted significantly slower compared with wild type and could not be stimulated by cAMP. In both wild-type and HCN4 -/- mice, cardiac cells with “primitive” pacemaker action potentials could be found. However, cardiac cells with “mature” pacemaker potentials, observed in wild-type embryos starting at day 9.0, were not detected in HCN4-deficient embryos. Thus, HCN4 channels are essential for the proper generation of pacemaker potentials in the emerging sinoatrial node.

11 June 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MSM. Sausbier
M. Sausbier
HHH. Hu
H. Hu
CAC. Arntz
C. Arntz
SFS. Feil
S. Feil
SKS. Kamm
S. Kamm
PRPeter Ruth
Peter Ruth
Malfunctions of potassium channels are increasingly implicated as causes of neurological disorders. However, the functional roles of the large-conductance voltage- and Ca 2+ -activated K + channel (BK channel), a unique calcium, and voltage-activated potassium channel type have remained elusive. Here we report that mice lacking BK channels (BK -/- ) show cerebellar dysfunction in the form of abnormal conditioned eye-blink reflex, abnormal locomotion and pronounced deficiency in motor coordination, which are likely consequences of cerebellar learning deficiency. At the cellular level, the BK -/- mice showed a dramatic reduction in spontaneous activity of the BK -/- cerebellar Purkinje neurons, which generate the sole output of the cerebellar cortex and, in addition, enhanced short-term depression at the only output synapses of the cerebellar cortex, in the deep cerebellar nuclei. The impairing cellular effects caused by the lack of postsynaptic BK channels were found to be due to depolarization-induced inactivation of the action potential mechanism. These results identify previously unknown roles of potassium channels in mammalian cerebellar function and motor control. In addition, they provide a previously undescribed animal model of cerebellar ataxia.